Universität zu Köln

Article

Schneider, Carlo, Faßbender, Patricia and Völker, Linus ORCID: 0000-0002-4461-6128 (2026). Paraneoplastische Rhabdomyolyse. Die Innere Medizin, 67 (1). pp. 118-122. Springer Nature. ISSN 2731-7080

Lindemann, Christoph Heinrich ORCID: 0000-0001-5966-3018, Burst, Volker ORCID: 0000-0002-0256-6628, Völker, Linus Alexander ORCID: 0000-0002-4461-6128, Brähler, Sebastian, Simic, Dusan ORCID: 0000-0002-7325-9481, Becker, Ingrid ORCID: 0000-0001-5829-3553, Hellmich, Martin ORCID: 0000-0001-5174-928X, Kurscheid, Clarissa, Scholten, Nadine ORCID: 0000-0002-7793-7745, Krauspe, Ruben, Leibel, Kerstin ORCID: 0009-0008-5234-4856, Stock, Stephanie ORCID: 0000-0002-1726-9300 and Brinkkoetter, Paul Thomas ORCID: 0000-0002-4287-2080 (2024). Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial. Trials, 25 (1). pp. 1-16. Springer Nature. ISSN 1745-6215

Osterholt, Thomas ORCID: 0000-0001-5047-0252, Todorova, Polina Georgieva ORCID: 0000-0002-4728-224X, Kühne, Lucas ORCID: 0000-0002-5990-0279, Ehren, Rasmus ORCID: 0000-0002-3245-7481, Weber, Lutz T. ORCID: 0000-0003-4116-598X, Grundmann, Franziska ORCID: 0000-0002-5766-7477, Benzing, Thomas ORCID: 0000-0003-0512-1066, Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 and Völker, Linus A. ORCID: 0000-0002-4461-6128 (2023). Repetitive administration of rituximab can achieve and maintain clinical remission in patients with MCD or FSGS. Scientific Reports, 13 (1). p. 6980. Springer Nature. ISSN 2045-2322

Kühne, Lucas ORCID: 0000-0002-5990-0279, Völker, Linus A. ORCID: 0000-0002-4461-6128, Hagmann, Henning ORCID: 0000-0002-2624-2740, Hägele, Holger, Osterholt, Thomas ORCID: 0000-0001-5047-0252, Eichenauer, Dennis A. ORCID: 0000-0002-1927-3514, Thomas, Andreas, Breuer, Johanna, Grüttner, Berthold, Gottschalk, Ingo, Kann, Martin, Benzing, Thomas ORCID: 0000-0003-0512-1066, Thevis, Mario, Müller, Annette M. and Brinkkötter, Paul T. ORCID: 0000-0002-4287-2080 (2022). First use of the anti‐VWF nanobody caplacizumab to treat iTTP in pregnancy. British Journal of Haematology, 196 (3). e30-e33. Wiley-Blackwell. ISSN 0007-1048